Based on the consensus analyst ratings on 2,483 stocks held in TSGUX.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TSGUX Analyst Price Target
Average Price Target
$21.17
Based on 2,483 Wall Street analysts offering 12 month price targets to Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund holdings in the last 3 months. The average price target is $21.17 with a high forecast of $24.70 and a low forecast of $17.88. The average price target represents a 19.55% change from the last price of $17.71.
What is TSGUX’s average 12-month price target, according to analysts?
Based on analyst ratings, Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund’s 12-month average price target is $21.17.
What is TSGUX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSGUX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSGUX a Buy, Sell or Hold?
Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund has a consensus rating of Moderate Buy which is based on 1629 buy ratings, 792 hold ratings and 62 sell ratings.
What is Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund’s price target?
The average price target for Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund is $21.17. This is based on 2483 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $24.70 ,the lowest forecast is $17.88. The average price target represents N/A Increase from the current price of N/A.
What do analysts say about Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund?
Morgan Stanley Pathway Funds - Small-Mid Cap Equity Fund’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2483 Wall Streets Analysts.
How can I buy shares of TSGUX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.